Immunome Inc (NASDAQ: IMNM) on Friday, plunged -5.84% from the previous trading day, before settling in for the closing price of $10.11. Within the past 52 weeks, IMNM’s price has moved between $8.97 and $30.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 17.82%. With a float of $69.65 million, this company’s outstanding shares have now reached $84.67 million.
The firm has a total of 55 workers. Let’s measure their productivity. In terms of profitability, gross margin is 88.22%, operating margin of -3134.4%, and the pretax margin is -3014.59%.
Immunome Inc (IMNM) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Immunome Inc is 17.74%, while institutional ownership is 63.10%. The most recent insider transaction that took place on Jan 31 ’25, was worth 1,162,500. In this transaction President and CEO of this company bought 150,000 shares at a rate of $7.75, taking the stock ownership to the 669,636 shares. Before that another transaction happened on Nov 21 ’24, when Company’s President and CEO bought 66,057 for $9.54, making the entire transaction worth $630,263. This insider now owns 485,693 shares in total.
Immunome Inc (IMNM) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.69 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.01% during the next five years compared to -48.48% drop over the previous five years of trading.
Immunome Inc (NASDAQ: IMNM) Trading Performance Indicators
Immunome Inc (IMNM) is currently performing well based on its current performance indicators. A quick ratio of 6.17 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 79.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.12, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -3.09 in one year’s time.
Technical Analysis of Immunome Inc (IMNM)
Analysing the last 5-days average volume posted by the [Immunome Inc, IMNM], we can find that recorded value of 0.66 million was lower than the volume posted last year of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 8.57%. Additionally, its Average True Range was 0.79.
During the past 100 days, Immunome Inc’s (IMNM) raw stochastic average was set at 8.83%, which indicates a significant increase from 0.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.56% in the past 14 days, which was higher than the 73.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.85, while its 200-day Moving Average is $12.90. Now, the first resistance to watch is $10.16. This is followed by the second major resistance level at $10.79. The third major resistance level sits at $11.12. If the price goes on to break the first support level at $9.20, it is likely to go to the next support level at $8.87. Should the price break the second support level, the third support level stands at $8.24.
Immunome Inc (NASDAQ: IMNM) Key Stats
Market capitalization of the company is 806.11 million based on 79,777K outstanding shares. Right now, sales total 14,020 K and income totals -106,810 K. The company made 2,910 K in profit during its latest quarter, and -47,100 K in sales during its previous quarter.
